FIELD: chemistry.
SUBSTANCE: invention relates to a crystalline form of A (S)-1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulphonyl)ethanone.
EFFECT: technical result is obtaining a crystalline form of A (S)-1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulphonyl)ethanone, as well as a veterinary composition and a method of treating parasitic infection or infestation with parasites in an animal in need thereof is described.
13 cl, 7 dwg, 5 tbl, 3 ex
| Title |
Year |
Author |
Number |
| SPIROCYCLIC ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS |
2012 |
- Billen Denis
- Chabb Nehtehn Ehntoni Logan
- Kertis Majkl
- Grinvud Shon Didablju
- Menon Sandzhaj
- Stak Timoti
- Vehjllankurt Vehleri A.
|
RU2566083C2 |
| ISOXAZOLINE DERIVATIVES AS ANTI-PARASITIC AGENTS |
2011 |
- Chabb Nehtehn A.L.
- Kertis Majkl Pol
- Khouson Uil'Jam
- Kajn Grehkhehm M.
- Menon Sandzhaj Radzhagopal
- Shikhan S'Juzan Mehri Kalt
- Skalitski Donal'D Dzhejms
- Vajllankurt Vehleri Ehnn
- Uehndt Dzhon A.
|
RU2551354C2 |
| CRYSTALLINE FORM OF CALCIUM SALT OF BIS-[(E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULPHONYL)AMINO]-PYRIMIDIN-5-YL](3R, 5S)-3, 5-DIHYDROXYHEPT-6-ENOIC ACID |
2004 |
- But Rebekka Dzhejn
- Sittern Piter Ehntoni
- Krabb Dzheffri Norman
- Khorberi Dzhon
- Dzhouns Dejvid Uin Kalvert
|
RU2363697C2 |
| CRYSTALLINE FORMS OF (S)-4-AMINO-N-(1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE |
2013 |
|
RU2652377C2 |
| NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID |
2011 |
|
RU2612556C2 |
| CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]BENZOIC ACID, AND USE THEREOF AND METHODS FOR PREPARING |
2007 |
- Al'Msted Nil G.
- Khvang Piter Seongvoo
- Moon Joung-Choon
|
RU2474577C2 |
| CRYSTAL (6S,9AS)-N-BENZYL-8-({6-[3-(4-ETHYLPIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN-2-YL}METHYL)-6-(2-FLUORINE-4-HYDROXYBENZYL)-4,7-DIOXO-2-(PROP-2-EN-1-YL)HEXAHYDRO-2H-PYRAZINO[2,1-C][1,2,4]TRIAZINE-1(6H)-CARBOXAMIDE |
2016 |
|
RU2723551C2 |
| POLYMORPHIC MODIFICATIONS OF N-[(3-FLUORO-4-METHOXYPYRIDINE-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({ 4-[(2-OXOPYRIDINE-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AND THEIR SALTS |
2017 |
- Beaton, Haydn
- Crowe, David Malcolm
- Edwards, Hannah Joy
- Griffiths-Haynes, Nicholas James
|
RU2756273C2 |
| NEW CRYSTALLINE FORM OF 2-{3-[2-(1-{[3,5-BIS(DIFLUOROMETHYL)-1H-PYRAZOL-1-YL]ACETYL}PIPERIDIN-4-YL)-1,3-THIAZOL-4-YL]-4,5-DIHYDRO-1,2-OXAZOL-5-YL}-3-CHLOROPHENYLMETHANE SULPHONATE |
2014 |
- Olenik Britta
- Khillebrand Shtefan
- Vasner Perr
- Vajss Martin
- Vakhendorff-Nojmann Ulrike
|
RU2691948C2 |
| CRYSTAL FORM OF PARP-1 INHIBITOR AND ITS PRODUCTION METHOD |
2018 |
- Li, Wenhai
- Zhang, Quanliang
- Qiu, Zhenjun
- Li, Zhengming
|
RU2792620C2 |
